Behavioral correction of Parkinsonian rats following the transplantation of immortalized fibroblasts genetically modified with TH and GCH genes.
Eukaryotic plasmid vectors encoding the tyrosine hydroxylase (TH) gene and GTP cyclohydrolase-1 (GCH) gene were constructed and introduced into immortalized fibroblasts obtained from SV40 large antigen (LT(AG)) transformed rat primary fibroblasts. TH and GCH positive clones were selected and identified by immunohistochemistry and RT-PCR, respectively. Hemi-parkinsonian rats created using 6-hydroxydopamine (6-OHDA) were used to assess the therapeutic effect created by the co-implantation of immortalized fibroblasts genetically modified by TH or GCH genes. Animal behavior was significantly improved two weeks following implantation and behavioral correction was maintained for over 14 weeks. Behavioral improvement was paralleled by exogenous TH gene expression, identified by TH immunohistochemistry and RT-PCR analyses. The transplanted cells survived for at least 38 weeks as demonstrated by fibronectin immunohistochemical staining. Tumor formation or host reaction was not seen, although TH expression was negative for 20 weeks after the implantation. This work demonstrates that the co-transplantation of immortalized fibroblasts genetically modified by TH and GCH genes may be developed as a valuable approach to the treatment of Parkinson's disease.
Chen
S
S
Department of Neurology, Clinical and Research Center for Parkinson Disease, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, People's Republic of China. chen_sd@medmail.com.cn
Xianwen
Chen
C
Dehua
Xu
X
Zhenguo
Liu
L
Lingfei
Xu
X
Smith
S W
SW
Zhongcheng
Zheng
Z
D000818:Animals; D001522:Behavior, Animal; D001708:Biopterins / Q000031:analogs & derivatives* / Q000096:biosynthesis; D001921:Brain / Q000201:enzymology; D002461:Cell Line, Transformed / Q000637:transplantation; D017690:Cell Transplantation / Q000379:methods*; D003714:Denervation; D005347:Fibroblasts / Q000166:cytology / Q000637:transplantation; D006136:GTP Cyclohydrolase / Q000235:genetics*; D015971:Gene Expression Regulation, Enzymologic; D015316:Genetic Therapy / Q000379:methods*; D016627:Oxidopamine; D010300:Parkinson Disease / Q000628:therapy*; D051381:Rats; D012867:Skin / Q000166:cytology; D013565:Sympatholytics; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics*
D013565:Sympatholytics; D001708:Biopterins; D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase; D006136:GTP Cyclohydrolase; C003402:sapropterin